Literature DB >> 16690162

Retardation of organo-bromides in a fractured chalk aquitard.

Shai Ezra1, Shimon Feinstein, Alex Yakirevich, Eilon Adar, Itzhak Bilkis.   

Abstract

This study investigates the mechanisms controlling the distribution of 3-bromo-2,2-bis(bromomethyl)propanol (TBNPA) and 2,2-bis(bromomethyl)propan-1,3-diol (DBNPG) in a fractured chalk aquitard. An extensive monitoring program showed a systematic decrease in the TBNPA/DBNPG ratio with distance from the contamination source. Sorption of TBNPA on the white and/or gray chalks comprising the aquitard is approximately one order of magnitude greater than that of DBNPG. This results in more efficient removal of TBNPA from the fracture into the porous matrix and thus decreases the TBNPA/DBNPG ratio in the fracture water. Mathematical modeling of solute transport in the fracture domain illustrates the probable importance of sorption in controlling the spatial variation in TBNPA and DBNPG ratio.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690162     DOI: 10.1016/j.jconhyd.2006.02.016

Source DB:  PubMed          Journal:  J Contam Hydrol        ISSN: 0169-7722            Impact factor:   3.188


  3 in total

1.  Comparison of 2,2-bis(bromomethyl)-1,3-propanediol induced genotoxicity in UROtsa cells and primary rat hepatocytes: relevance of metabolism and oxidative stress.

Authors:  Weixi Kong; Pengfei Gu; Gabriel A Knudsen; I Glenn Sipes
Journal:  Toxicol Lett       Date:  2013-08-13       Impact factor: 4.372

2.  Induction of DNA damage in human urothelial cells by the brominated flame retardant 2,2-bis(bromomethyl)-1,3-propanediol: role of oxidative stress.

Authors:  Weixi Kong; Robert K Kuester; Alfred Gallegos; I Glenn Sipes
Journal:  Toxicology       Date:  2011-10-14       Impact factor: 4.221

3.  Absorption, distribution, metabolism, and excretion of 2,2-bis(bromomethyl)-1,3-propanediol in male fischer-344 rats.

Authors:  Simone I Hoehle; Gabriel A Knudsen; J Michael Sanders; I Glenn Sipes
Journal:  Drug Metab Dispos       Date:  2008-11-24       Impact factor: 3.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.